Lamdong Pharmaceutical JSC (HNX:LDP)
Vietnam · Delayed Price · Currency is VND 10,800
0.00 (0.00%)
At close: Aug 5, 2025
HNX:LDP Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 | 2016 - 2020 |
| 235,837 | 217,958 | 186,001 | 187,415 | 161,902 | 379,664 | Upgrade | |
Revenue Growth (YoY) | 23.61% | 17.18% | -0.75% | 15.76% | -57.36% | -12.08% | Upgrade |
Cost of Revenue | 161,383 | 153,567 | 148,835 | 149,895 | 140,678 | 303,243 | Upgrade |
Gross Profit | 74,454 | 64,390 | 37,166 | 37,519 | 21,225 | 76,420 | Upgrade |
Selling, General & Admin | 62,263 | 51,110 | 49,512 | 62,833 | 41,013 | 78,898 | Upgrade |
Operating Expenses | 62,263 | 51,110 | 49,512 | 62,833 | 41,013 | 78,898 | Upgrade |
Operating Income | 12,191 | 13,280 | -12,347 | -25,314 | -19,788 | -2,477 | Upgrade |
Interest Expense | -3,797 | -4,979 | -7,027 | -7,544 | -2,210 | -5,987 | Upgrade |
Interest & Investment Income | 688.27 | 281.55 | 775.36 | 2,862 | 31,615 | 617.9 | Upgrade |
Other Non Operating Income (Expenses) | -385.92 | -299.96 | 21.67 | -8,851 | 31,105 | 21,814 | Upgrade |
EBT Excluding Unusual Items | 8,696 | 8,283 | -18,576 | -38,848 | 40,721 | 13,967 | Upgrade |
Gain (Loss) on Sale of Investments | -1,428 | -1,428 | -634.63 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 63.64 | 63.64 | -894.01 | - | - | - | Upgrade |
Pretax Income | 7,332 | 6,919 | -20,105 | -38,848 | 40,721 | 13,967 | Upgrade |
Income Tax Expense | - | - | - | 43.69 | 2,850 | 4,382 | Upgrade |
Net Income | 7,332 | 6,919 | -20,105 | -38,891 | 37,870 | 9,586 | Upgrade |
Net Income to Common | 7,332 | 6,919 | -20,105 | -38,891 | 37,870 | 9,586 | Upgrade |
Net Income Growth | - | - | - | - | 295.07% | - | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | 8 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 8 | Upgrade |
Shares Change (YoY) | 2.60% | - | 0.01% | -0.02% | 62.22% | 0.04% | Upgrade |
EPS (Basic) | 562.84 | 544.66 | -1582.67 | -3062.00 | 2981.00 | 1224.00 | Upgrade |
EPS (Diluted) | 562.84 | 544.66 | -1583.00 | -3062.00 | 2981.00 | 1224.00 | Upgrade |
EPS Growth | - | - | - | - | 143.55% | - | Upgrade |
Free Cash Flow | -4,136 | 5,835 | 5,977 | -46,718 | 21,392 | 1,132 | Upgrade |
Free Cash Flow Per Share | -317.48 | 459.36 | 470.51 | -3678.26 | 1683.88 | 144.56 | Upgrade |
Gross Margin | 31.57% | 29.54% | 19.98% | 20.02% | 13.11% | 20.13% | Upgrade |
Operating Margin | 5.17% | 6.09% | -6.64% | -13.51% | -12.22% | -0.65% | Upgrade |
Profit Margin | 3.11% | 3.17% | -10.81% | -20.75% | 23.39% | 2.53% | Upgrade |
Free Cash Flow Margin | -1.75% | 2.68% | 3.21% | -24.93% | 13.21% | 0.30% | Upgrade |
EBITDA | 18,302 | 20,093 | -4,110 | -16,414 | -8,047 | 6,384 | Upgrade |
EBITDA Margin | 7.76% | 9.22% | -2.21% | -8.76% | -4.97% | 1.68% | Upgrade |
D&A For EBITDA | 6,111 | 6,813 | 8,237 | 8,900 | 11,742 | 8,861 | Upgrade |
EBIT | 12,191 | 13,280 | -12,347 | -25,314 | -19,788 | -2,477 | Upgrade |
EBIT Margin | 5.17% | 6.09% | -6.64% | -13.51% | -12.22% | -0.65% | Upgrade |
Effective Tax Rate | - | - | - | - | 7.00% | 31.37% | Upgrade |
Revenue as Reported | 235,837 | 217,958 | 186,001 | 187,415 | 161,902 | 379,664 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.